Page last updated: 2024-11-03

pyridinolcarbamate and Pus

pyridinolcarbamate has been researched along with Pus in 2 studies

Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shor, NA1
Helunenko, AM1
Petrunia, AM1
Zelenyĭ, II1
Gal'perin, EI1
Tatishvili, GG1
Akhaladze, GG1
Sakevarashvili, GR1
Nasirov, FN1
Aref'ev, AE1

Other Studies

2 other studies available for pyridinolcarbamate and Pus

ArticleYear
[Disorders of the blood microcirculation in patients with suppurative-necrotic complications in diabetes mellitus and the approaches to their correction].
    Klinichna khirurhiia, 1998, Issue:1

    Topics: Adult; Aged; Chronic Disease; Combined Modality Therapy; Conjunctiva; Diabetes Mellitus, Type 1; Dia

1998
[Disorders of organic hemodynamics of the liver and their correction in suppurative cholangitis].
    Khirurgiia, 1991, Issue:9

    Topics: Acute Disease; Animals; Aprotinin; Ascorbic Acid; Aspirin; Cholangitis; Cholestasis; Dextrans; Dipyr

1991